Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2476 AL 2490

Unraveling brain diseases: The promise of brain-on-a-chip models

Cerutti L, Brofiga M.

J Neurosci Methods. 2024 May;405:110105. doi: 10.1016/j.jneumeth.2024.110105. Epub 2024 Mar 7.

Targeting phosphodiesterase 4 as a potential therapy for Parkinson's disease: a review

Nongthombam PD, Haobam R.

Mol Biol Rep. 2024 Apr 15;51(1):510. doi: 10.1007/s11033-024-09484-8.

The impact of physical therapy on dysphagia in neurological diseases: a review

Li K, Fu C, Xie Z, Zhang J, Zhang C, Li R, Gao C, Wang J, Xue C, Zhang Y, Deng W.

Front Hum Neurosci. 2024 Jun 6;18:1404398. doi: 10.3389/fnhum.2024.1404398. eCollection 2024.

Neuro-regeneration or Repair: Cell Therapy of Neurological Disorders as A Way Forward

Song XY, Fan CX, Rahman AU, Choudhary MI, Wang XP.

Curr Neuropharmacol. 2024;22(14):2272-2283. doi: 10.2174/1570159X22666240509092903.

Lipids and α-Synuclein: adding further variables to the equation

Schepers J, Löser T, Behl C.

Front Mol Biosci. 2024 Aug 12;11:1455817. doi: 10.3389/fmolb.2024.1455817. eCollection 2024.

Neuronal threshold functions: Determining symptom onset in neurological disorders

Jordi L, Isacson O.

Prog Neurobiol. 2024 Nov;242:102673. doi: 10.1016/j.pneurobio.2024.102673. Epub 2024 Oct 9.

Stem Cell Interventions in Neurology: From Bench to Bedside

Pappolla MA, Wu P, Fang X, Poeggeler B, Sambamurti K, Wisniewski T, Perry G.

J Alzheimers Dis. 2024;101(s1):S395-S416. doi: 10.3233/JAD-230897.

The Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Various Neurocognitive Disorders

Castro-Vidal ZA, Mathew F, Ibrahim AA, Shubhangi F, Cherian RR, Choi HK, Begum A, Ravula HK, Giri H.

Cureus. 2024 Oct 26;16(10):e72451. doi: 10.7759/cureus.72451. eCollection 2024 Oct.

Controversies and insights into PTBP1-related astrocyte-neuron transdifferentiation: neuronal regeneration strategies for Parkinson's and Alzheimer's disease

McDowall S, Bagda V, Hodgetts S, Mastaglia F, Li D.

Transl Neurodegener. 2024 Dec 3;13(1):59. doi: 10.1186/s40035-024-00450-9.

Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature review

Ansari U, Wen J, Syed B, Nadora D, Sedighi R, Nadora D, Chen V, Lui F.

AIMS Neurosci. 2024 Dec 24;11(4):505-519. doi: 10.3934/Neuroscience.2024031. eCollection 2024.

Assessing the factors that influence the utilization and delivery of rehabilitation services among persons with Parkinson's disease: A scoping review

Agoriwo MW, Joseph C, Franzén E, Unger M.

J Eval Clin Pract. 2024 Sep;30(6):873-886. doi: 10.1111/jep.13999. Epub 2024 May 16.

Potential Therapeutic Approach using Aromatic l-amino Acid Decarboxylase and Glial-derived Neurotrophic Factor Therapy Targeting Putamen in Parkinson's Disease

Tripathi RK, Goyal L, Singh S.

Curr Gene Ther. 2024;24(4):278-291. doi: 10.2174/0115665232283842240102073002.

Gut Microbiome and Its Role in Parkinson's Disease

Suresh SB, Malireddi A, Abera M, Noor K, Ansar M, Boddeti S, Nath TS.

Cureus. 2024 Nov 6;16(11):e73150. doi: 10.7759/cureus.73150. eCollection 2024 Nov.

Structural neuroimaging markers of normal pressure hydrocephalus versus Alzheimer's dementia and Parkinson's disease, and hydrocephalus versus atrophy in chronic TBI-a narrative review

Kadaba Sridhar S, Dysterheft Robb J, Gupta R, Cheong S, Kuang R, Samadani U.

Front Neurol. 2024 Mar 21;15:1347200. doi: 10.3389/fneur.2024.1347200. eCollection 2024.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias